CH Biotech R&D Co (TPE:6534) EPS (Basic): NT$4.52 (TTM As of Dec. 2025)


TPE:6534 CH Biotech R&D Co Ltd TPE:6534
84 GF Score
Price NT$90.20
GF Value NT$100.55
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is CH Biotech R&D Co EPS (Basic)?

CH Biotech R&D Co TPE:6534 +0.11% 84 EPS (Basic) is NT$4.52 as of Dec. 2025. GuruFocus rates TPE:6534 with a GF Score™ of 84/100 and a GF Value™ of NT$100.55 (Modestly Undervalued). The stock has 1 warning sign investors should review.

CH Biotech R&D Co's basic earnings per share (Basic EPS) for the three months ended in Dec. 2025 was NT$0.42. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2025 was NT$4.52.

CH Biotech R&D Co's EPS (Diluted) for the three months ended in Dec. 2025 was NT$0.42. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was NT$4.49.

CH Biotech R&D Co's EPS without NRI for the three months ended in Dec. 2025 was NT$0.42. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2025 was 4.58.

During the past 3 years, the average EPS without NRI Growth Rate was -0.90% per year. During the past 5 years, the average EPS without NRI Growth Rate was 28.60% per year. During the past 10 years, the average EPS without NRI Growth Rate was 8.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, CH Biotech R&D Co's highest 3-Year average EPS without NRI Growth Rate was 66.30% per year. The lowest was -30.60% per year. And the median was -0.40% per year.

CH Biotech R&D Co  (TPE:6534) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

CH Biotech R&D Co EPS (Basic) Related Terms

CH Biotech R&D Co EPS (Basic) Historical Data

* Premium members only.

The historical data trend for CH Biotech R&D Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CH Biotech R&D Co EPS (Basic) Chart

CH Biotech R&D Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.00 4.79 4.76 4.63 4.51

CH Biotech R&D Co Quarterly Data
Jun20 Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.18 3.89 0.37 -0.16 0.42
TPE:6534
84GF Score
CH Biotech R&D Co Ltd TPE:6534
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CH Biotech R&D Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

CH Biotech R&D Co's Basic EPS for the fiscal year that ended in Dec. 2025 is calculated as

Basic EPS (A: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(464.001-0)/102.800
=4.51

CH Biotech R&D Co's Basic EPS for the quarter that ended in Dec. 2025 is calculated as

Basic EPS (Q: Dec. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(43.805-0)/102.800
=0.43

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$4.52

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of NT$4.52 mean?
CH Biotech R&D Co (TPE:6534) has a EPS (Basic) of NT$4.52 as of Dec. 2025. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on CH Biotech R&D Co and its competitors.
Is CH Biotech R&D Co's EPS (Basic) too high?
CH Biotech R&D Co's current EPS (Basic) is NT$4.52. Overall, CH Biotech R&D Co has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does CH Biotech R&D Co's EPS (Basic) compare to CTVA and CF?
CH Biotech R&D Co's EPS (Basic) of NT$4.52 can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for an Agriculture company?
A good EPS (Basic) depends on the Agriculture industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on CH Biotech R&D Co and its competitors. CH Biotech R&D Co's current EPS (Basic) is NT$4.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CH Biotech R&D Co stock overvalued right now?
Based on GuruFocus' analysis, CH Biotech R&D Co (TPE:6534) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$100.55, compared to a current price of NT$90.20 — trading 10.3% below its estimated fair value. The current EPS (Basic) is NT$4.52. CH Biotech R&D Co's overall GF Score™ is 84/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For CH Biotech R&D Co (TPE:6534), the current EPS (Basic) is NT$4.52 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CH Biotech R&D Co (TPE:6534) Overvalued in 2026?

Based on GuruFocus' analysis, CH Biotech R&D Co stock appears to be undervalued. The current stock price of NT$90.20 is trading 10.3% below its estimated GF Value™ of NT$100.55. GuruFocus considers CH Biotech R&D Co to be Modestly Undervalued.

Key valuation signals for TPE:6534:

  • EPS (Basic): NT$4.52
  • GF Value™: NT$100.55 vs. price of NT$90.20 (10.3% below fair value)
  • GF Score™: 84/100 with 1 warning sign

No single metric tells the full story. See the TPE:6534 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

CH Biotech R&D Co Business Description

Address No. 89, Wenxian Road, Nantou County, Nantou City, TWN, 540001
CH Biotech R&D Co Ltd is a Taiwan-based company engaged in the manufacture and sales of fertilizer, as well as providing biotechnology services. It is engaged in the research, development, manufacturing, and sales of proprietary plant growth regulators and specialty micronutrient fertilizers. It offers NutriSync 3D plant growers in the form of boron and molybdenum, NutriSync D liquid formulation for dicot crops, CHB-HS for reducing carbon emissions in crop production, CHB-BB2, fruit quality enhancers, and other related products. The company has one reportable segment, Agricultural Biotechnology. Geographically, it derives maximum revenue from the United States, and the rest from other countries.
84GF Score

Get the complete analysis for TPE:6534

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$90.20
Price
NT$100.55
GF Value